Good Growth Capital is an early-stage venture capital firm specializing in transformative science and technology investments. Founded in 2015, the firm is a majority women-owned team comprising entrepreneurs, financial experts, technologists, and visionaries with a keen eye for early potential. They focus on sectors such as life sciences, data sciences, and green technology, including medical devices, therapeutics, diagnostics, analytics (AI, NLP, ML), clean energy, and advanced materials.

The firm is headquartered in Charleston, South Carolina, with an additional office in Boston, Massachusetts. Good Growth Capital is recognized for its commitment to diversity, with over 75% of its portfolio companies led by diverse founders. In June 2022, the firm closed its oversubscribed third fund, Good Growth Capital General Fund II, with more than $100 million, marking it as one of the largest early-stage funds in the Southeast.